Arvinas, Inc. (ARVN) Misses Q4 EPS by 39c

Arvinas, Inc. (NASDAQ: ARVN) reported Q4 EPS of ($1.56), $0.39 worse than the analyst estimate of ($1.17). Revenue for the quarter came in at $38 million versus the consensus estimate of $35.72 million.

For earnings history and earnings-related data on Arvinas, Inc. (ARVN) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• FDA approves Pfizer's Ibrance for HR+, HER2+ metastatic breast cancer
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears